Detalles de la búsqueda
1.
Nationwide data from comprehensive genomic profiling assays for detecting driver oncogenes in non-small cell lung cancer.
Cancer Sci
; 115(5): 1656-1664, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38450844
2.
Prospective Observational Study of Ramucirumab Plus Docetaxel After Combined Chemoimmunotherapy in Patients With Non-Small-Cell Lung Cancer.
Oncologist
; 29(5): e681-e689, 2024 May 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38241181
3.
High levels of AXL expression in untreated EGFR-mutated non-small cell lung cancer negatively impacts the use of osimertinib.
Cancer Sci
; 114(2): 606-618, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36169649
4.
Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced non-small cell lung cancer.
Invest New Drugs
; 40(2): 403-410, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34633575
5.
Long-term survival data of patients with limited disease small cell lung cancer: a retrospective analysis.
Invest New Drugs
; 40(2): 411-419, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34716848
6.
Impact of weight loss on treatment with PD-1/PD-L1 inhibitors plus chemotherapy in advanced non-small-cell lung cancer.
Support Care Cancer
; 30(2): 1633-1641, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34550461
7.
Retrospective analysis of osimertinib re-challenge after osimertinib-induced interstitial lung disease in patients with EGFR-mutant non-small cell lung carcinoma.
Invest New Drugs
; 39(2): 571-577, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32955628
8.
Rechallenge with previously administered epidermal growth factor receptor-tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer with leptomeningeal metastasis.
Invest New Drugs
; 39(6): 1732-1741, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34259953
9.
Association between oligo-residual disease and patterns of failure during EGFR-TKI treatment in EGFR-mutated non-small cell lung cancer: a retrospective study.
BMC Cancer
; 21(1): 1247, 2021 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34798865
10.
Long-term outcomes in extensive disease small cell lung cancer patients treated without immune checkpoint inhibitors.
Jpn J Clin Oncol
; 51(12): 1736-1743, 2021 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34642738
11.
Detection of programmed cell death-ligand 1 using 22C3 antibody in patients with unresectable stage III non-small cell lung cancer receiving chemoradiotherapy.
Int J Clin Oncol
; 26(4): 659-669, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33415571
12.
The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR-T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations.
BMC Cancer
; 18(1): 1241, 2018 Dec 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30537950
13.
Correction to: Prognostic impact of pneumonitis after durvalumab therapy in patients with locally advanced nonsmall cell lung cancer.
Invest New Drugs
; 40(2): 464, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34748131
14.
Efficacy of second-line chemotherapy in patients with pulmonary large cell neuroendocrine carcinoma.
Sci Rep
; 14(1): 7641, 2024 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38561461
15.
AXL signal mediates adaptive resistance to KRAS G12C inhibitors in KRAS G12C-mutant tumor cells.
Cancer Lett
; 587: 216692, 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38342232
16.
Prognostic impact of clinical factors for immune checkpoint inhibitor with or without chemotherapy in older patients with non-small cell lung cancer and PD-L1 TPS ≥ 50.
Front Immunol
; 15: 1348034, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38464519
17.
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101).
Target Oncol
; 19(3): 423-433, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38613731
18.
A protocol of a single arm, prospective, open-label, multicenter, phase II study of ramucirumab and erlotinib in treatment-naïve non-small cell lung cancer patients with EGFR mutation and brain metastases (SPIRAL-BRAIN study).
Transl Lung Cancer Res
; 12(8): 1802-1806, 2023 Aug 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37691860
19.
Clinical impact of tumour burden on the efficacy of PD-1/PD-L1 inhibitors plus chemotherapy in non-small-cell lung cancer.
Cancer Med
; 12(2): 1451-1460, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35848053
20.
Incidence and Treatment Outcome of Radiation Pneumonitis in Patients With Limited-stage Small Cell Lung Cancer Treated With Concurrent Accelerated Hyperfractionated Radiation Therapy and Chemotherapy.
Adv Radiat Oncol
; 8(2): 101129, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36845617